| Tara Lorraine Branton, MD | |
|
8930 Blakeney Professional Dr, Charlotte, NC 28277-6660 | |
| (704) 667-3500 | |
| Not Available |
| Full Name | Tara Lorraine Branton |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 8930 Blakeney Professional Dr, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568432920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2009-01422 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
Meaningful use of Electronic Health Record (EHR) systems is more than an IT or clinical initiative, according to Reonel "Joon" Saddul, Vice President, Clinical Informatics, at St. Joseph Health System. It is an organizational initiative. Implementation could cost the organization three times more than it should, if not done right from the start, therefore, Saddul advises that all parties are included in the decision-making and planning processes, and the projects aligned to known and likely future requirements.
A detailed report, available on the preprint server medRxiv*, describes the various facets of the second wave that set it apart from the first. The report also contains the findings of an extended SIR model that explored the potential effects of intervention at various time points in the second wave.
Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.
Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.
› Verified 1 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
Meaningful use of Electronic Health Record (EHR) systems is more than an IT or clinical initiative, according to Reonel "Joon" Saddul, Vice President, Clinical Informatics, at St. Joseph Health System. It is an organizational initiative. Implementation could cost the organization three times more than it should, if not done right from the start, therefore, Saddul advises that all parties are included in the decision-making and planning processes, and the projects aligned to known and likely future requirements.
A detailed report, available on the preprint server medRxiv*, describes the various facets of the second wave that set it apart from the first. The report also contains the findings of an extended SIR model that explored the potential effects of intervention at various time points in the second wave.
Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.
Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.
› Verified 1 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
Meaningful use of Electronic Health Record (EHR) systems is more than an IT or clinical initiative, according to Reonel "Joon" Saddul, Vice President, Clinical Informatics, at St. Joseph Health System. It is an organizational initiative. Implementation could cost the organization three times more than it should, if not done right from the start, therefore, Saddul advises that all parties are included in the decision-making and planning processes, and the projects aligned to known and likely future requirements.
A detailed report, available on the preprint server medRxiv*, describes the various facets of the second wave that set it apart from the first. The report also contains the findings of an extended SIR model that explored the potential effects of intervention at various time points in the second wave.
Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.
Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tara Lorraine Branton, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Tara Lorraine Branton, MD 8930 Blakeney Professional Dr, Charlotte, NC 28277-6660 Ph: (704) 667-3500 |
News Archive
Meaningful use of Electronic Health Record (EHR) systems is more than an IT or clinical initiative, according to Reonel "Joon" Saddul, Vice President, Clinical Informatics, at St. Joseph Health System. It is an organizational initiative. Implementation could cost the organization three times more than it should, if not done right from the start, therefore, Saddul advises that all parties are included in the decision-making and planning processes, and the projects aligned to known and likely future requirements.
A detailed report, available on the preprint server medRxiv*, describes the various facets of the second wave that set it apart from the first. The report also contains the findings of an extended SIR model that explored the potential effects of intervention at various time points in the second wave.
Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.
Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.
› Verified 1 days ago
Lillian M. Teigland, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6324 Fairview Rd, Suite 201, Charlotte, NC 28210 Phone: 704-384-0588 Fax: 704-384-0580 | |
Felice A James, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 251 Eastway Dr, Charlotte, NC 28213 Phone: 704-446-9991 | |
Heather M. Burney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Rozzelles Ferry Rd, Charlotte, NC 28208 Phone: 704-446-9987 | |
Dr. Jerome Howard, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6111 Rumple Rd, Charlotte, NC 28262 Phone: 704-596-5067 Fax: 704-599-9458 | |
Vishalakshi Kalyana Sundaram, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Vail Ave, Ste 400, Charlotte, NC 28207 Phone: 704-304-7000 | |
Thamrah Rhoxana Wright, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1918 Randolph Rd Ste 275, Charlotte, NC 28207 Phone: 704-384-1354 | |
Dr. Carlos B Jorge, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 309 S Sharon Amity Rd Ste 206, Charlotte, NC 28211 Phone: 704-360-5018 Fax: 980-273-1102 |